UnitedHealth Group consensus stays robust, Wall Street lifts targets on the shares

UnitedHealth Group draws a consistently positive analyst picture on the NYSE, with several houses raising their price targets in June and the next earnings update scheduled for mid-July.

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-23, 14:47.

UnitedHealth Group (US91324P1021) remains a core healthcare name on the NYSE, trading around 406 dollars per share as of the latest close. The Tuesday focus is the analyst consensus, with several research houses lifting their price targets for the Dow Jones component in recent weeks, according to MarketScreener and TrendSpider data. MarketScreener overview of UnitedHealth Group

What recent analyst notes show

Across Wall Street, the UnitedHealth Group shares carry a predominantly positive stance, with a majority of analysts rating the stock Buy or Outperform, according to aggregated ratings. MarketScreener lists recent updates from JPMorgan, Leerink Partners and others, with target prices that broadly sit above the current share level. Consensus data on UnitedHealth Group

In mid-June, Leerink Partners adjusted its price target on UnitedHealth from 400 to 462 dollars while maintaining an Outperform rating, reinforcing the constructive view on the healthcare group. JPMorgan earlier lifted its target from 420 to 466 dollars and kept an Overweight rating, underlining the stock’s status as a key defensive growth name in the US healthcare sector. Leerink Partners target increase on UnitedHealth

Consensus picture ahead of July earnings

UnitedHealth Group is scheduled to report its next quarterly earnings on July 16, 2026, according to TrendSpider’s calendar for the UNH ticker. The current share price of roughly 406 dollars sits below several recent price targets, leaving a gap that investors watch in the run-up to the update. TrendSpider data on UNH

TrendSpider lists UnitedHealth at 406.45 dollars in recent trading, with a 52-week high near 415.96 dollars and the next earnings date marked for mid-July, which anchors the near-term news flow. Consensus expectations typically focus on the performance of the Optum health services unit and medical cost trends in the UnitedHealthcare insurance arm, key drivers for margin and cash generation. UNH quote and earnings calendar

How UnitedHealth Group earns its money

UnitedHealth Group generates most of its revenue through the UnitedHealthcare insurance segment and the Optum health services platform. UnitedHealthcare offers employer-sponsored and government-backed health plans, while Optum provides pharmacy benefit management, data analytics and care delivery, giving the group a diversified healthcare services footprint.

Where the UnitedHealth Group shares trade today

The UnitedHealth Group shares (US91324P1021) trade on the NYSE under the ticker UNH, at 406.68 dollars as of June 22, 2026, 20:00 UTC, based on Trading Dashboard data. The stock is part of the Dow Jones Industrial Average and the S&P 500, positioning it among the leading US blue chips.

Key data on the UnitedHealth Group shares

• Company: UnitedHealth Group Incorporated
• ISIN: US91324P1021
• WKN: 869561
• Ticker: UNH
• Trading venue: NYSE
• Price (as of 2026-06-22, 20:00): 406.68 USD
• Market cap: around 380 billion USD (as of June 2026, according to MarketScreener)
• Sector / industry: Health Care / Managed Health Care
• Index membership: Dow Jones Industrial Average, S&P 500
• Next earnings date: 2026-07-16

Disclaimer: This article is for informational purposes only and does not constitute investment advice, tax advice or a recommendation to buy or sell securities. All data are based on sources cited and believed to be reliable at the time of writing, but may change. Readers should conduct their own research or consult a professional advisor before making investment decisions.